Bellicum Pharmaceuticals is a biopharma company developing novel cellular immunotherapies for various forms of cancer (both hematological and solid tumors), as well as orphan inherited blood disorders.
Bellicum Pharmaceuticals is a biopharma company developing novel cellular immunotherapies for various forms of cancer (both hematological and solid tumors), as well as orphan inherited blood disorders.
Immunovaccine develops cancer immunotherapies and infectious disease vaccines based on a patented formulation providing controlled and prolonged exposure of antigens and adjuvant to the immune system : DepoVax.